Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents

Por Aragon-Ching, Jeanny B., Ning, Yang-Min, Chen, Clara C., Latham, Lea, Guadagnini, Jean-Pierre, Gulley, James L., Arlen, Philip M., Wright, John J., Parnes, Howard, Figg, William D., Dahut, William L.
Publicado em 2009

Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Por Ning, Yang-Min, Gulley, James L., Arlen, Philip M., Woo, Sukyung, Steinberg, Seth M., Wright, John J., Parnes, Howard L., Trepel, Jane B., Lee, Min-Jung, Kim, Yeong Sang, Sun, Haihao, Madan, Ravi A., Latham, Lea, Jones, Elizabeth, Chen, Clara C., Figg, William D., Dahut, William L.
Publicado em 2010